SHPMY.US Shanghai Pharmaceuticals Holding Co Ltd ADR

Healthcare Health Care Providers & Services USA Stocks
27.71 USD
Close of Nov 17, 2026
6.85 7.50
Market cap
USD 5.09B
P/E
6.8x
P/B
0.45x
ROE
7.7%
Dividend yield
4.83%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SHPMY.US undervalued?

Graham number
Price27.71
Graham value74.92
Discount63.0%

SHPMY.US trades 63.0% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Pharmaceuticals Holding Co Ltd ADR fundamental analysis

No fundamental analysis for Shanghai Pharmaceuticals Holding Co Ltd ADR yet.

Shanghai Pharmaceuticals Holding Co Ltd ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Pharmaceuticals Holding Co Ltd ADR

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, n…

Full company profile